Skip to main content
Livermore
Livermore
ZHEN

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Aravive, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of ARAV: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders49145−3
Shares5.91M37.8K4.75M−1.12M (−19.0%)
Value$35.3M$227.0K$17.7M−$17.4M (−49.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Aravive, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ARAV in Q3 2021
InstitutionSharesValue% of portfolio
Franklin Resources Inc37,800$141.0K0.00%
Jacobs Levy Equity Management, Inc12,127$45.0K0.00%
Virtu Financial LLC10,861$40.0K0.00%
Massmutual Trust Co FSB9,300$35.0K0.00%
Cutler Group LP700$2.00K0.00%

Sold out (8)

Institutions that held Aravive, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ARAV in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
FMR LLC456,443$2.73M
Gsa Capital Partners LLP88,102$527.0K
Tibra Equities Europe Ltd56,200$336.0K
Jane Street Group, LLC47,821$286.0K
Trexquant Investment LP11,181$67.0K
New York State Common Retirement Fund84$1.00K
Deutsche Bank AG104$1.00K
Citigroup Inc1$0

Not filed for Q3 2021 yet (1)

Institutions that held Aravive, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARAV in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
QS Investors, LLC37,800$227.0K